The nucleoside analog, 3’-azido-3’-deoxythymidine (Zidovudine, AZT), is a major component in the first-line therapy for HIV-1 infection worldwide. HIV-1 infected patients treated long-term with AZT often become resistant, and different mechanisms have been proposed. Two possible mechanisms are ...
BiochemistryPoster